Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 1, 1999, Pages 28-33

  Thulin, T ^b   Lehtonen, A ^a   Dahlof C ^b   Nilsson Ehle, P ^b   Engqvist, L ^b   Lagerstedt, C ^b   Berglund, E ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Atenolol; Diltiazem; Glucose; Hypertension; Lipids; Urate

Indexed keywords

ATENOLOL; CAPTOPRIL; DILTIAZEM; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; UNILOC; URATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; SINGLE BLIND PROCEDURE; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD GLUCOSE; CAPTOPRIL; DILTIAZEM; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; QUALITY OF LIFE; SINGLE-BLIND METHOD; TIME FACTORS; URIC ACID;

EID: 0032895215     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Andrén L, Höglund P, Dotewall A, Eggertsen R, Svensson A, Olsson S-O, Wadenvik H 1988 Diltiazem in hypertensive patients with type II diabetes mellitus. Am J Cardiol 62: 114G-120G
2. Boden WE, Moss AJ, Herbert PN, Saritelli A, Oakes D, Eberly S 1994 Effect of long-term diltiazem administration on serum lipids in postmyocardial survivors. Multicenter Diltiazem Post-Infarction Trial Research Group. Am J Cardiol 73: 513-514
3. Frishman WH, Charlap S, Goldberger J, Kimmel B, Stroh J, Sorsa F, Allen L, Strom J 1985 Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. Am J Cardiol 56 (Suppl H): 41H-46H
4. Lehtonen A, Marniemi J 1984 Effect of atenolol on plasma HDL cholesterol subfractions. Atherosclerosis 51: 335-338
5. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshmm R, Gottdiener J, Ramirez EA, Henderson WG 1993 Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 328:914-921
6. Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S 1989 Metabolic effects of diltiazem and atenolol: Results from a randomized, double-blind study with parallel groups. J Hypertens 7: 551-559
7. Pool PE, Seagram SC, Salel AF 1985 Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol 56: 68H-91H
8. Thulin T, Almkvist H, Berglund L, Björnsson T, Fagher B, Henningsen N, Honkavaara M, Naukkarinen V, Nordenström P. Sillanpää J, West R 1994 Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension - a double-blind randomised dose finding study. Cardiovasc Drug Ther 8: 845-849
9. Thulin T, Hedner T, Gustafsson S, Olsson S-O 1991 Diltiazem compared to metoprolol as add-on therapies to diuretics in hypertension. J Hum Hypertens 5: 107-114
10. Weidmann P, Uehlinger DE, Gerher A 1985 Antihypertensive treatment and serum lipoproteins. J Hypertens 3: 297-306
11. Weir MR 1995 Diltiazem: Ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 35: 220-232